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APPENDIX 3CIntroduction to the Synthesis and
Purification of Oligonucleotides
Avery’s realization that DNA carries the genetic information lead chemists on a 40-year
search that has culminated in efficient, automated oligonucleotide synthesis on solid-
phase supports. Modern nucleic acid synthesizers utilize phosphite triester chemistries
that employ stable phosphoramidite monomers to build the growing polymer (see UNIT
3.3). These robust reactions allow both chemists and molecular biologists to easily generate
specific ribo- and deoxyribo oligonucleotides with a variety of labels, modified linkages,
and nonstandard bases attached throughout the chain. The synthesis of short (less than
40-nucleotide) probes and primers requires no more special expertise than the ability to
read the synthesizer operator’s manual, and longer oligonucleotides (up to 150 nucleo-
tides) can be synthesized with greater care.
The introductory section of this appendix provides strategies for the maximization of
synthetic yield, the generation of sequences containing site-specific modifications, and
the isolation of synthetic oligonucleotides. Protocols describe monitoring the progress of
synthesis via the trityl assay (see Basic Protocol 1 and Support Protocol) and methods for
deprotection of DNA (see Basic Protocol 2) and RNA (see Basic Protocol 3) oligonu-
cleotides.
This appendix augments the detailed instructions provided by the manufacturers of
oligonucleotide synthesizers. A functional understanding of the synthesis chemistries,
coupled to insights on the mechanical operation of the synthesizer, will allow the user to
minimize input time and maximize oligonucleotide output.
INTRODUCTION TO CHEMICAL NUCLEIC ACID SYNTHESIS
Many hydroxyl and amine moieties make nucleic acids very animated molecules with
rich chemistries of their own that can interfere with the phosphite triester reactions used
to couple the nucleotide monomers; therefore, protection strategies are necessary in
chemical synthesis to mask the functional groups on the monomers so that the only
significant reaction is the desired 3′ to 5′ sequential condensation of monomers to the
growing oligonucleotide. These synthetic protecting groups must be chosen so that they
can be removed easily to expose the natural nucleotides.
The fully protected monomers for nucleic acid synthesis are generally called phos-
phoramidites (Fig. A.3C.1; also see recipe in Reagents and Solutions). In traditional
protection schemes the nucleophilic amino moieties on the bases are protected (see UNIT
2.1) with either isobutyryl (N-2 of guanine) or benzoyl (N-6 of adenine and N-4 of cytidine)
groups, both of which can be removed at the completion of synthesis by ammoniolysis.
However, recent advances have lead to the widespread use of phenoxyacetyl (PAC)
protection of adenosine, dimethylformadine (DmF) protection of guanosine, and acyl
protection of cytosine to yield oligonucleotides that can be deprotected rapidly under very
mild conditions (Reddy et al., 1994). The 5′ primary hydroxyl of the ribose sugar is
protected (see UNIT 2.3) with a dimethoxytrityl (DMT) ether moiety which is removed by
mild protic acids at the beginning of each coupling cycle. The efficiency of synthesis at
each coupling cycle can be monitored by detecting the release of the chromophore trityl
cation. To synthesize nucleic acids with the natural phosphodiester backbone, the 3′
secondary hydroxyl function of the ribose sugar is derivatized with a highly reactive
phosphitylating agent. The phosphate oxygen on this moiety is usually masked by
β-cyanoethoxy and diisopropylamine protecting groups. By insulating the phosphate
oxygen with alternative groups, modified phosphate backbones may be accessed. Finally,
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for ribonucleic acids the secondary 2′ hydroxyl of the ribose is shielded throughout the
chemical synthesis by the tert-butyldimethylsilyl group (UNIT 2.2).
The convenience of using these protecting groups for automated nucleic acid synthesis is
that they yield nearly lesion-free natural nucleic acids with high efficiency through simple
hydrolysis, nucleophilic displacement, and redox chemistries. In a standard synthesis
cycle, the nucleotide chain grows from an initial protected nucleoside derivatized via its
terminal 3′ hydroxyl to a solid support (see UNIT 3.1). Reagents and solvents are pumped
through the support to induce the consecutive removal and addition of sugar protecting
groups in order to isolate the reactivity of a specific chemical moiety on the monomer
and effect its stepwise addition to the growing oligonucleotide chain. This design
eliminates the need to purify synthetic intermediates or unreacted reagents, because they
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Figure A.3C.1 Structure of nucleoside phosphoramidite units, showing traditional protection
groups for 2′ hydroxyl, phosphate, and base moieties. For DNA, Z = H (no protection required); for
RNA, Z = O-protection group.
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are simply rinsed off the column at the end of each chemical step. Assembly of the
protected oligonucleotide chain is carried out in four chemical steps: deblocking, activa-
tion/coupling, oxidation, and capping (Fig. A.3C.2). Cleavage and deprotection then
reveal the single-stranded nucleic acid.
Deblocking
The synthesis cycle begins with the removal of the acid-labile DMT ether from the 5′
hydroxyl of the 3′ terminal nucleoside. This is usually accomplished by using dichlo-
roacetic acid (DCA) in dichloromethane. The resulting trityl cation chromophore can be
quantitated to determine coupling efficiency (see Basic Protocol 1). After deblocking, the
5′ hydroxyl is the only reactive nucleophile capable of participating in the subsequent
coupling step. Since the nitrogenous bases of the growing DNA chain are susceptible to
acid-catalyzed depurination, the deblocking step is short, and an acetonitrile rinse
thoroughly removes the deblocking agent from the support. Also, coupling efficiency and
accuracy are increased by this wash, since premature detritylation of the incoming
phosphoramidite monomer is prevented.
Activation/Coupling
Following deblocking of the 5′ hydroxyl group, the next protected phosphoramidite is
delivered to the reaction column along with the weakly acidic activator tetrazole (pKa =
4.8). Nucleophilic attack of the previously freed 5′ hydroxyl upon the incoming monomer
elongates the nucleic acid chain. Because this protonated phosphoramidite is so reactive,
the coupling reaction is usually complete within 30 sec. A molar excess of tetrazole over
the phosphoramidite ensures complete activation, and a molar excess of phosphoramidite
over free 5′ hydroxyls of the growing chain promotes efficient coupling. To optimize the
coupling efficiency, the amounts of reagents injected and the coupling time can be varied
(see Synthesizing Long Oligonucleotides).
Capping
In spite of these efficiency measures, a small percentage of the support-bound nucleo-
side’s 5′ hydroxyls do not couple to the incoming activated monomer. They must be
rendered inactive to minimize deletion products and simplify the purification process.
Usually, acetic anhydride and N-methylimidazole dissolved in pyridine and tetrahydro-
furan (THF) act to create an acylating agent that “caps” the unextended 5′ hydroxyls. The
5′ acetyl ester cap is unreactive in all subsequent cycles and is removed during the final
ammonia deprotection step. Additional acetonitrile washing subsequent to capping can
increase synthetic yield. After coupling and capping, the internucleotide linkage is a
trivalent phosphite triester that is extremely unstable and must be oxidized to a phosphotri-
ester, which will ultimately yield natural DNA.
Oxidation
In the last step of the cycle, the unstable phosphite triester linkages are oxidized to a more
stable phosphotriester by 0.02 M iodine dissolved in water/pyridine/THF (see recipe for
oxidizer). An iodine-pyridine adduct forms to the phosphite triester and is subsequently
displaced by water to yield phosphorus oxidized to the pentavalent state. Pyridine also
neutralizes the hydrogen iodide byproduct. Because the oxidizer contains water, the
support is rinsed several times with acetonitrile following this reaction. One cycle of
monomer addition is then complete, and another cycle begins with the removal of the 5′
DMT from the previously added monomer.
Cleavage/Deprotection
At the end of the synthesis, the final trityl can either be removed with a final acid wash
(“trityl-off”), or be left on for purification purposes (“trityl-on”). The oligonucleotide
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Figure A.3C.2 Steps in the assembly of the protected oligonucleotide chain.
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itself is removed from the support with concentrated ammonium hydroxide. Additionally,
this treatment deprotects the phosphorus by β-elimination of the cyanoethyl group and
removes the protecting groups from the heterocyclic bases to yield a single-stranded
nucleic acid.
RNA Synthesis
RNA chemical synthesis is identical to that used for DNA except for the need for an
additional protecting group at the 2′ hydroxyl of ribose. This position is usually protected
with tert-butyldimethyl silyl groups, which are stable throughout the synthesis (Fig.
A.3C.1). They are removed at the final deprotection step by addition of a basic fluoride
ion such as tetrabutylammonium fluoride (TBAF). The remaining positions on both the
sugar and the bases are protected in the same fashion as for DNA. By adjusting several
parameters in the DNA synthesis protocol—including the coupling times, monomer
delivery rate, frequency of washing steps, and types of capping reagents—stepwise
coupling efficiencies of up to 99% can be obtained (Wincott et al., 1995; G. Glick, pers.
comm.). However, for the casual user this yield represents the exception rather than the
norm, and only shorter oligoribonucleotides (<20 bases) should initially be attempted.
STRATEGIES FOR NUCLEIC ACID SYNTHESIS
A Checklist for Nucleic Acid Synthesis
Consistency and planning are the keys to reliable nucleic acid synthesis. Organizing these
repetitive tasks into a standard operating protocol will streamline efficiency and produce
better-quality oligonucleotides.
1. Plan syntheses to optimize machine use. Oligonucleotides of similar size should be
combined in parallel runs, since synthesizing many short oligonucleotides followed
by a longer one is faster than mixing the sets on dual-column synthesizers.
2. Determine the total number of bases to be incorporated. Be sure there are enough of
the required reagents and phosphoramidites available for the entire synthesis. Consult
the synthesizer manual for the amount of reagent needed for each coupling (also see
Troubleshooting). Remember that different synthetic scales (e.g., 0.25 µmol versus
1 µmol) require different amounts of reagents. Syntheses should be planned so that
a phosphoramidite is almost completely exhausted. Also, phosphoramidites that have
been dissolved for >2 weeks should be replaced.
3. Consider special programming requirements. Many synthesis options pertaining to
the scale of the synthesis, backbone composition, and presence of protecting groups
can be modified. Create a log for users to fill out detailing exact synthesis require-
ments, and check the log prior to synthesis. A computerized log book is especially
useful and allows for an organized oligonucleotide nomenclature (e.g., R20.17 may
refer to Rebecca’s 20-mer, the 17th 20-mer made on the system).
4. If the synthesizer lacks a trityl monitor, set up a fraction collector to monitor the
chromophoric trityl cation release (see Basic Protocol 1).
5. Initialize the system. If previous oligonucleotides were cleaved from their supports
automatically, rinse the columns for 30 sec with acetonitrile to remove any remaining
traces of ammonium hydroxide. If the machine has been at rest for >6 hr, immediately
before starting the synthesis (and following the addition of fresh reagents) remove
any stale reagents or moisture from the lines by priming them. This will maximize
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the first coupling step’s efficiency. Check the reagent and phosphoramidite flow rates
to ensure that reagents are being properly delivered.
6. Start the synthesis. Confirm that the flow through the lines and columns is not
obstructed and monitor the first few trityl releases. An abortive synthesis of a 60-mer
sequence wastes much more material than a failed 3-mer run.
Synthesizing Long Oligonucleotides (≥100 Bases)
Modern synthesizers can routinely produce sequences of 150 or more nucleotides in
usable amounts (≥10 µg). Several strategies can be employed to enhance the yield from
syntheses longer than 100 bases (UNIT 3.3).
1. Exclude water from the system (the importance of this cannot be overstated; see
Critical Parameters). Replace reagents on the machine with fresh ones before all long
syntheses. This is particularly important for the phosphoramidites and especially for
guanosine phosphoramidite, since it decomposes more quickly than the other two
protected bases (Zon et al., 1985).
2. Monitor trityl releases for shorter runs prior to attempting the synthesis of long
oligonucleotides to limit wastage of expensive reagents. In general, if the stepwise
efficiency of synthesis is <99%, alter parameters to increase the efficiency on shorter
sequences before attempting to synthesize a long oligonucleotide (see Basic Proto-
col 1).
3. Use dichloroacetic acid (DCA) rather than trichloroacetic acid (TCA) for deblocking
if the synthesizer is compatible with this reagent. Depurination (cleavage of the
glycosidic bond) under acidic conditions is a prominent side reaction that ultimately
limits DNA synthesis. DCA tends to show much better synthetic yields than trichlo-
roacetic acid, especially for longer oligonucleotides (R. Pon, pers. comm.). Use a 2%
(v/v) DCA/1,2-dichloroethane mixture.
4. Modify the synthesis protocol to increase the coupling time of the phosphoramidite.
Also, additional methylene chloride wash steps included prior and subsequent to
deblocking, along with increased acetonitrile washing subsequent to capping, lead to
increased yields (G. Glick, pers. comm.).
5. Increase the phosphoramidite concentration to enhance the coupling efficiency—e.g.,
use a concentration of 50 mg/ml (double the normal concentration; 20-fold molar
excess over the synthetic polynucleotide chain) for longer sequences.
6. Using a support matrix such as control pore glass (CPG; UNIT 3.1) with a loading
capacity of <40 µmol/g can greatly increase yields of long oligonucleotide. Further-
more, the pore size of the support should be 1000 Å for >100-mers and 2000 Å for
200-mers (Gait, 1984) to alleviate molecular crowding and steric effects. For a typical
1-µmol-scale synthesis of a 150-mer, 20 mg of a support with a loading capacity of
5 mmol/g is used.
If it is too difficult to synthesize the desired sequence in a reasonable yield, or if oligomers
>150 bases are desired, the nucleic acids may be made in segments and ligated (Bartel
and Szostak, 1993) following PCR with a proofreading polymerase such as Pfu or Tth.
Note, however, that since PCR is usually a mutagenic procedure, any products generated
should be checked by sequencing. Also, very long synthetic oligonucleotides (300 to 600
bases) have also been synthesized directly, and in spite of incredibly low yields, rare
full-length products have been successfully amplified by PCR (Ciccarelli et al., 1991).
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Finally, mutually primed synthesis (e.g., CPMB UNIT 8.2) can also be a suitable option for
oligomers >150 bases.
Synthesizing RNA
Since many structural and mechanistic studies are underway concerning catalytic RNAs,
the catalog of commercially available modified RNA monomers has recently bloomed
(Table A.3C.1). RNA chemical synthesis (see UNIT 3.5) has become as routine as that of
DNA (see UNIT 3.3) and typically uses identical 5′-dimethoxytrityl-β-cyanoethyl-protected
phosphoramidites except for an additional protecting group on the 2′ hydroxyl (see UNIT
2.2). tert-Butyldimethylsilyl protection of the 2′-hydroxyl group is the basis of most
commercially available RNA phosphoramidites, since the silyl group is stable to both
acid and base and can be removed with fluoride ion. Recently, however, RNA monomers
with 2′-acetal groups (FPMP, CEE; also see UNIT 2.2) have appeared; these have the
advantage of being conveniently removed at pH 2 just prior to use of the particular sample
of RNA. Strategies for ribophosphoramidite protection are an active area of research, and
recent work with 5′-silyl ethers in conjunction with 2′-orthoester protection has proven
particularly interesting (S. Scaaringe, pers. comm.). For the casual user of RNA, it is often
easier just to purchase small quantities of the required sequence from a ribo-oligonu-
cleotide synthesis company such as Baron Consulting, Dharmacon Research, Genosys,
or Peninsula Labs (see SUPPLIERS APPENDIX).
Isomeric purity of the phosphoramidites is often variable because of the difficulties
inherent in distinguishing between the vicinal hydroxyls of ribose. If a homogeneous
population of 5′-to-3′-linked oligoribonucleotides is required (as in most cases),
then a thin-layer chromatography (TLC) or 31P nuclear magnetic resonance
(NMR) analysis of the starting phosphoramidites should be performed to establish
their isomeric composition. While phosphorus NMR facilities are not generally
available to molecular biologists, TLC is both inexpensive and straightforward.
Recommended solvent systems to separate the 2′ and 3′ ribonucleotide phos-
phoramidites are 1:1 ether/chloroform, or 40:58:2 or 50:46:4 dichloromethane/hex-
ane/triethylamine (Usman et al., 1987).
With a few slight modifications, the procedures and precautions described for DNA
synthesis chemistry apply to RNA as well (UNIT 3.5). Since stepwise coupling efficiency
is lower than that of DNA, even greater care should be taken to exclude water completely
from the closed system. Because the 2′ hydroxyl is often protected with sterically
hindering protecting groups, reaction times for RNA reagents tend to be longer, and
adjustments should be made to phosphoramidite concentrations and coupling times, as
detailed below. As is true for all RNA work, equipment and reagents that will contact
unprotected oligonucleotides should be RNase free to avoid degradation of the synthe-
sized material.
Depending on the synthesizer and coupling program used, RNA phosphoramidites are
suspended in dry acetonitrile at a concentration of 0.1 to 1.0 M with a 6- to 10-fold excess
of reagents delivered per 300 sec coupling. S-ethyltetrazole and DCI have also been found
to be a more effective activators than the traditional tetrazole (Sproat et al., 1995; Vargeese
et al, 1998). Also, additional methylene chloride washing steps included prior to and
subsequent to deblocking, along with increased acetonitrile washing subsequent to
capping, lead to increased yields (G. Glick, pers. comm.).
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Table A.3C.1 Suppliers of Unnatural and Modified Phosphoramidites
Phosphoramidite typea Suppliersb
Fast/mild deprotecting DNA  and RNA monomers Cruachem
Glen Research
Perkin-Elmer
BioGenex
ChemGenes
PerSeptive BioSystems
Sigma
Modified DNA monomers Appligene
Interactiva BioTechnologie
Glen
ChemGenes
Cruachem
Sigma
Perkin-Elmer
Solid Phase Science
Convertible deoxynucleosides Glen Research
Radiolabeled deoxyphosphoramidites Cambridge Isotopes
Modified RNA monomers ChemGenes
BioGenex
Boehringer Mannheim
Glen Research
Dalton
Perkin-Elmer
Sigma
Cruachem
Labeling monomers Clontech
Cruachem
Glen Research
Solid Phase Science
Perkin-Elmer
BioGenex
Sigma
ChemGenes
Boehringer Mannheim
ABI Biotechnology
PerSeptive BioSystems
Genosys
Uniquely structured oligonucleotide branched
or cyclic
Clontech
Glen Research
Non-enzymatically extended 3′ ends Glen Research
Alternative backbones Glen Research
ChemGenes
aAll phosphoramidites are 5′ DMT and 3′ cyanoethyl protected (CED) unless otherwise noted.
bSee Suppliers Appendix for supplier contact information.
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Incorporation of Modified Nucleosides
Chemical nucleic acid synthesis allows for the incorporation of unnatural or modified
bases, as well as a variety of labeling moieties, into an oligonucleotide (see Chapter 4).
This can be extremely useful for testing models of structural interactions between
enzymes and nucleic acids, selecting labeled molecules from a population of unlabeled
ones, or gaining insights into the parameters that govern nucleic acid structure and
chemistry. Modified backbone chemistries such as phosphorothioates, phosphoroami-
dates, and phosphotriesters are also readily available. In general, the bases themselves
can be obtained commercially and are handled like any other phosphoramidite; however,
consult the company that supplies the analog about necessary modifications to programs
or reagents (see Table A.3C.1). Typically, the only adjustment needed is to dissolve the
modified base at a somewhat higher concentration than normal to overcome problems
associated with reactivity. Most of the methods used to increase the yield of long and
ribo-oligonucleotides may be applied to the synthesis of modified nucleic acids.
When synthesizing modified oligonucleotides, compatibilities of the chemistries, place-
ment of modifications relative to other chemical groups, and 5′ to 3′ directionality are all
factors to consider. Generally when an oligonucleotide is end-labeled/modified, a long
flexible tether is added to allow greater accessibility. Stretches of four deoxythymines are
often used for this purpose. Also, adding deoxythymines 5′ to the label (5′-TTTT-label-3′)
can aid in separating labeled molecules from unlabeled ones by size. Note that some
tagging phosphoramidites allow for the enzymatic extension or kinasing of the modified
oligonucleotide, while others do not. Finally, oligonucleotides may also be synthesized
directly on solid glass supports (Cohen et al., 1997).
Terminal transferase can be used as an alternative means of incorporating modified bases
at the 3′ end of an oligonucleotide (Ratliff, 1982; e.g., CPMB UNIT 3.6). This enzyme is
tolerant of a variety of substrates, and has been used to add deoxynucleotide triphosphates
derivatized at virtually every position (C-8 on adenine, any of the amino groups, C-5 on
cytosine, O-6 on guanosine) to DNA. It also functions, though less well, with RNA bases.
It can use any DNA oligonucleotide that is at least 2 bases long [d(pXpX)] and contains
a free 3′ hydroxyl as a primer. A potential problem in preparing homogeneous polynu-
cleotides using terminal transferase is that a statistically random number of bases is added
to the 3′ end of the template (with the exception of molecules such as cordycepin, which
act as chain terminators due to the absence of 3′ hydroxyl). If a single species is desired,
it can be gel purified. Polynucleotide phosphorylase may also be used to incorporate
modified bases at the 3′ end (Gillam and Smith, 1980).
A more controlled means of introducing modified nucleotides relies on T4 RNA ligase
and substrates of the form A(5′)ppX (where X can be virtually any molecule, including
for example ribose or amino acids, in a pyrophosphate linkage with adenosine; Uhlenbeck
and Gumport, 1982). The minimal template for reactions of this form is a trinucleoside
containing a free 3′ hydroxyl. RNA reacts much better than DNA, and single-strand
molecules act as better templates than double-stranded ones. Since 3′ hydroxyl groups
are required, substrates of the form A(5′)ppXp will undergo only a single round of
addition, unlike the similar reaction with terminal transferase. In some cases, the com-
pound A(5′)ppXp can be generated directly by RNA ligase from pXp and ATP, although
the substrate requirements for the X moiety are much more strict than in the ligation
reaction. Thus, while virtually any dinucleotide of the form A(5′)ppX can be added to an
oligonucleotide, only a few compounds (primarily sterically “small” derivatives of natural
bases) can be used by the enzyme to form A(5′)ppXp from pXp.
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T4 RNA ligase can catalyze the ligation of single-stranded oligonucleotides in the
presence of ATP and various analogs (Kinoshita et al., 1997). Templates prepared by
terminal transferase or by T4 RNA ligase that contain modified nucleotides (or other
adducts) at their 3′ termini may be able to act as substrates in this reaction. This would
allow modified nucleotides to be introduced into the middle of a longer chain. However,
the substrate specificity of the enzyme for the 3′ hydroxyl donor is highly substrate
dependent and will have to be determined empirically.
Synthesizing Degenerate Oligonucleotides
Current combinatorial and “irrational” nucleic acid design methodologies focus on the
ability to create large pools of random sequences from which useful sequences may be
culled (Szostak, 1992; also see Chapter 9). In addition, random mutagenesis using
degenerate oligonucleotides allows for the exploration of “sequence space” surrounding
a given protein or RNA structure. Sequences can be produced that give a completely
random distribution of nucleotides at a given position or, alternatively, the sequence can
be biased or “doped” toward a particular base with only a low level of randomization.
Most synthesizers can be programmed for in-line degenerate mixing of bases, which is
useful if only a few positions are to be randomized. A potential problem with this method
is that, if mixing is incomplete, the sequence will be skewed toward whichever phos-
phoramidite enters the column first, since the reaction of the activated phosphoramidite
with the free 5′ hydroxyl is extremely fast. Therefore, while in-line mixing will generate
all base substitutions at a given position, the distribution of these substitutions may not
be uniform. If a statistically random distribution of nucleotides is required or if long
stretches of random sequence are to be made, it is better to manually mix the phos-
phoramidites together and use this mixture for the degenerate position. A true random
distribution may be obtained by mixing A, C, G, and T phosphoramidites in a 3:3:2:2
molar ratio to compensate for the faster coupling times of G and T phosphoramidites (D.
Bartel, pers. comm.). On synthesizers where phosphoramidites are loaded without de-
taching the bottle, the mixing generated by sequential loading of each phosphoramidite
into the extra bottle is sufficient to generate randomized sequences.
Oliphant and Struhl (Oliphant et al., 1986; Oliphant, 1989) have constructed degenerate
oligonucleotides using mixed phosphoramidites, but have modified the synthesis protocol
by deleting the capping step during the random additions. This increases the overall yield
of long oligonucleotides, since sequences that fail to elongate are not terminated, and the
size of the final product is more heterogeneous. This method is particularly useful if
deletions, as well as randomized bases, in a given sequence are required.
Hermes et al. (unpub. observ.) have developed a detailed protocol for producing statisti-
cally mutated oligonucleotides. This method employs in-line mixing between pure
phosphoramidite contained in separate bottles and equimolar mixtures of the four bases
contained in an additional bottle. The obvious advantage of such a method is that doped
and clean sequences can be synthesized on the same oligonucleotide. Whether or not this
method is employed, it is an example of how to dissect the chemistry of mixed-site
oligonucleotide synthesis. Hermes et al. (1989) have shown that mutations introduced by
this method are indeed statistically random.
Regardless of the strategy employed, the level of misincorporation of an oligonucleotide
should be decided in advance by the mutagenesis frequency desired. Quantitatively, this
level is given by the probability distribution:
P (n,m,x) = [m!/(m − n)!n!][x]n [1 − x]m×n
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where P is the probability of finding n errors in an oligonucleotide m in length with x
level of misincorporation (fraction “wrong” nucleotides delivered). This equation de-
scribes a Poisson distribution. If primarily single mutations are desired, then x should be
maximized for n = 1; if multiple mutations (e.g., doubles, or triples in a single oligonu-
cleotide) are necessary, x should be correspondingly higher. If the mix is optimized for n
mutations, then n − 1 and n + 1 mutations will occur in roughly equal amounts and n
mutations will be the most frequent.
Cloning randomized oligonucleotides can be difficult, since a complementary wild-type
sequence will generate mismatches that may result in biased correction in vivo. To avoid
this problem, second-strand synthesis can be primed from a nonrandom portion of the
sequence, or mutually primed synthesis (e.g., CPMB UNIT 8.2) can be utilized. Alternatively,
Derbyshire et al. (1986) describe the direct cloning of doped single-strand material with
“sticky ends” into a double-stranded cloning vector. Finally, Reidhaar-Olson and Sauer
(1988) describe the synthesis of complementary oligonucleotides containing inosine
(which can pair with any of the four natural bases) directly across from randomized
codons. This method resulted in the successful introduction of a wide variety of mutations
into the gene for lambda repressor, although there was a slight compositional bias in
cloned sequences.
STRATEGIES FOR OLIGONUCLEOTIDE PURIFICATION
Deprotected nucleic acids may be purified and isolated by a variety of methods. The
method of choice will depend on the availability of resources, the purity required—some
methods cannot separate (n−1)-mers from n-mers—and time considerations. Any of the
methods described below can be used to clean up crude material.
Isolation Methods
Precipitation
Direct precipitation of the nucleic acids constitutes a fast and efficient purification from
contaminating small molecules such as urea and phenol, but does not allow for purification
of abortive synthesis products from the full-length one. If oligonucleotide size separation
is required, this method should be used in conjunction with some of the other methods
described. After deprotection, resuspend the whitish pellet obtained in water. Add MgCl2
to a final concentration of 10 mM and mix along with 5 vol ethanol. Precipitation should
be immediate. Freeze the sample briefly at −20° or −70°C. Centrifuge the precipitated
material, wash with 95% ethanol, dry, and resuspend in water.
Precipitated deoxyoligonucleotides can be used for sequencing or cloning. They can also
be used in PCR reactions, although the efficiency of amplification may be reduced as
compared to gel-purified oligonucleotides. If the DNA is to be phosphorylated, a more
thorough purification procedure is necessary, since T4 polynucleotide kinase is inhibited
by lingering ammonium ions.
Sizing columns
Size-exclusion chromatography is extremely useful as a final purification step, especially
when small-molecule contamination occurs with otherwise pure oligonucleotides, but
(like precipitation) does not effect purification of abortive synthesis products from the
full-length one. If oligonucleotide size separation is required, this method should be used
in conjunction with some of the other methods described. Oligonucleotides purified by
PAGE might contain small amounts of low-molecular-weight contaminants such as urea
or phenol that might inhibit enzymatic reactions; sizing columns are a simple way to
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decontaminate these samples. Spin columns are simple to prepare and use, but gravity-
flow columns give better, more reproducible separation. The type of resin used should be
adjusted based on the size of the oligonucleotide being purified (e.g., Sephadex G-25 for
25-mers or less, G-50 for longer sequences).
Reversed-phase cartridges
A hydrophobic matrix may be used to separate full-length from abortive synthesis
products if the final trityl group is left on following the final monomer coupling reaction.
The resulting hydrophobically tagged full-length “trityl-on” oligonucleotide can be
separated easily from failure sequences, which lack trityl groups and do not efficiently
bind the hydrophobic matrix. Several companies supply columns designed specifically
for the purification of “trityl-on” oligonucleotides (e.g., Applied Biosystems oligonu-
cleotide purification cartridges). The procedure is simple and can be performed on a
number of samples in parallel within only a few minutes. The yield from such columns
is excellent, often >80% of the applied sample. However, although a majority of failure
sequences are removed using this method, many shorter sequences are co-purified with
the desired full-length material. Some of these fragments are due to cleavage of depuri-
nated DNA. These apurinic molecules can be eliminated prior to cleavage from the column
by treatment with lysine (Horn and Urdea, 1988). In addition, if care is not taken to wash
and elute samples from these columns slowly, some inhibitors (particularly of ligation
reactions) may co-elute.
Denaturing PAGE
Denaturing polyacrylamide gel electrophoresis (APPENDIX 3B) separates oligonucleotides
with single-residue resolution and is the method of choice for purifying full-length
oligonucleotides. However, the compatibility of the chemistries of modified nucleotides
incorporated into the nucleic acids and acrylamide matrix should be checked (thiolated
oligonucleotides seem to undergo Michael addition to the acrylamide, which renders them
irreversibly capped).
HPLC
Liquid chromatography can also separate oligonucleotides with single-residue resolution,
but its chief advantage is speed. Total run time can be as short as 30 min. The use of alkali
perchlorate salts has made ion exchange the HPLC method of choice given that long
oligonucleotide (>40 residues) may be easily purified in large scales (≥25 µmol; Sproat
et al., 1995; Warren and Vella, 1994). However, secondary structural migration anomalies
are generally more severe than those found with PAGE. Depending on the system
employed, the amount of oligonucleotide that can be purified in a single chromatographic
run can be comparable to PAGE, and sample recovery is typically >70%. For laboratories
with an HPLC system and a need to routinely purify short oligonucleotides with no
secondary structure, this method is ideal.
Oligonucleotides can be purified with HPLC by charge differences through ion exchange
or hydrophobicity if the final trityl group is left on following the ultimate monomer
coupling reaction. Only the “trityl-on” systems use buffers that can be lyophilized. A more
complete treatment of the complexities of oligonucleotide purification by HPLC can be
found in Applied Biosystems User Bulletin no. 13 on oligonucleotide purification
(Applied Biosystems, 1988).
Confirming the Oligonucleotide Sequence
Most oligonucleotides that are used for cloning need not be checked immediately after
synthesis, since the clones themselves will be checked after biological or enzymatic
amplification. However, in cases where a sequence will be used in a structural application
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such as mobility-shift assays (e.g., CPMB UNIT 12.1), filter-binding assays (e.g., CPMB UNIT
12.8), or crystallography, it is desirable to confirm the sequence. For almost all oligonu-
cleotides, this usually requires chemical sequencing (e.g., CPMB UNIT 7.5). Although
sequencing will confirm that the correct product was made, it cannot determine the
homogeneity. How unnatural or protected bases will react during chemical sequencing,
or how they will affect mobility on a sequencing gel, is not predictable. In order to
determine what fraction of molecules contain only the natural bases (A, T, C, and G), it
is necessary to digest the DNA enzymatically to completion and to examine its compo-
sition by a comparison with standard bases separated by HPLC. At least one HPLC buffer
system has been developed specifically for examining modified nucleosides in chemically
synthesized oligonucleotides (Eadie et al., 1987). The insertion and deletion rates for
chemical nucleic acid synthesis are non-negligible. The rate of insertions (presumably
due to DMT cleavage via tetrazole) has been measured to be as high as 0.4% per position,
and the rate of deletions (presumably due to incomplete capping) has been found to be as
high as 0.5% per position (A. Keefe and D. Wilson, pers. comm.). Therefore, for an
oligonucleotide 100 bases in length and assuming a random, noncorrelated mechanism
of action, only about 40% of the sequences will be the intended one. Finally, matrix-as-
sisted laser desorption/ionization mass spectrometry (MALDI-MS; UNIT 10.1), which has
recently emerged as a new biotechnology tool, may be used to determine the sequence of
deoxy and ribo-oligonucleotides of up to 60 bases (Zhu et al., 1997).
BASIC
PROTOCOL 1
MONITORING DNA SYNTHESIS USING THE TRITYL ASSAY
A trityl cation is released from the 5′ end of the growing oligonucleotide during each
synthesis cycle, and the yield of each step of the synthesis can be determined by
spectrophotometrically measuring the amount of trityl cation liberated. This procedure is
the simplest and most rapid means available for the identification of problems with
synthesized oligonucleotides prior to deprotection and purification. Also, in-line quanti-
tative trityl monitors can be interfaced to most synthesizers (Ana-Gen Technologies).
Materials
0.1 M para-toluene sulfonic acid (TSA; monohydrate) in acetonitrile (see recipe
for dry acetonitrile)
15-ml glass tubes (graduated, if possible)
1. Collect the trityl cation solution in 15-ml glass tubes after each step.
It is helpful to use graduated tubes so that a uniform final volume of acetonitrile can be
attained before assay.
2. Dilute the first three and last three fractions to 10 ml with 0.1 M TSA in acetonitrile.
Mix thoroughly.
CAUTION: Handle the solution consisting of dichloroacetic acid (or trichloroacetic acid)
in dichloromethane and acetonitrile with gloves, because it is corrosive as well as toxic.
Avoid prolonged contact with toxic acetonitrile fumes. Do not pipet by mouth.
Although 2.5 ml of deblocking solution is initially released, because acetonitrile is a volatile
liquid the volume may change during the course of a synthesis. Fractions may sit for several
days before being assayed without affecting the results. Samples that have evaporated to
dryness must be thoroughly redissolved. The acid ensures protonation of the trityl groups,
making them more strongly colored. It is misleading merely to visualize the yellow/orange
color of the fractions, however, since variable volumes of differing acidity are often
released.
3. Dilute each sample 20- to 50-fold in the same solution. Measure the absorbance at
498 nm versus acetonitrile/TSA.
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These dilutions are necessary because most spectrophotometers cannot accurately measure
absorbances >2.
4. Calculate the stepwise coupling efficiency and absolute yield for the synthesis as a
whole. The stepwise efficiency is given by:
where n is the number of trityl nucleotides in the oligonucleotide (equal to the length
of the oligonucleotide for trityl-off syntheses).
The absolute yield of product is given by:
where 70 µmol is the extinction coefficient of DMT.
The average stepwise efficiency is useful in determining the relative efficiency of each cycle
of the synthesis. The absolute yield is useful for determining how many milligrams of
product are present for subsequent purifications, although not all of the product will be of
the desired length.
The average absorbance of the first and last few steps is used to avoid discrepancies in
individual trityl assays. Clearly, if the synthesis was performed on a 1-mmol column, the
absolute yield in the first few fractions should be close to 1 mmol. A low absolute yield
(absorbance) in the first trityl release, followed by higher absolute yields (absorbances) in
the next few fractions, is sometimes observed. This is because some spontaneous detrityla-
tion occurs during storage of the columns and the trityls are subsequently rinsed off during
the prime lines program. In this case, the average stepwise efficiency should be calculated
with fractions 2 through 4. It should be noted that visual assessment of the trityl fractions
cannot begin to detect subtle differences (<5%) which may be critical in terms of overall
yield.
5. Perform troubleshooting assay (see Support Protocol) if average stepwise efficiency
is low.
SUPPORT
PROTOCOL
USING THE TRITYL ASSAY FOR TROUBLESHOOTING
If the average stepwise efficiency for the oligonucleotide synthesis is low, each fraction
should be assayed in order to diagnose the problem (what counts as a “low” yield depends
on the length and quantity of oligonucleotide desired). In general, synthetic efficiency
should be >99% per step, although lower stepwise efficiencies can be tolerated for short
oligonucleotides (<40 bases) or where yield is not critical.
Three classes of failures can be detected by trityl assays. A low absolute yield at the first
step followed by similarly low absorbances that results in a low overall yield is commonly
due to inefficient purging of activator or phosphoramidite lines prior to the synthesis. Such
a problem frequently occurs when a synthesizer has not been used for several days. Purge
the lines with dry reagents prior to starting the run to avoid inefficient synthesis. Most
machines have a priming program precisely for this purpose.
If the stepwise efficiency of each step is low, there is a systematic problem with one of
the common reagents, such as the acetonitrile. Often this is due to moisture in one or more
of the reagents, and it is more likely if reagents have not been recently replaced. The
phosphoramidites should be used until they are almost completely exhausted during a
( )stepwise efficiency average absorbance of last three fractions
average absorbance of first three fractions
n
=
µ
µ
mol DMT absorbance of last fraction) (dilution factor) (10 ml
70 ml / mol
=
× ×( )
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series of syntheses, so that fresh chemicals will be diluted as little as possible by older,
potentially wet material (see Critical Parameters).
Finally, individual trityl assays are most useful in determining when phosphoramidites
have become defective. In this case, drops in stepwise efficiency will only be seen at the
coupling steps involving the phosphoramidites in question.
Many problems, such as inefficient oxidation or product depurination, cannot be detected
by the trityl cation assay. Therefore, the trityl assay procedure should be used in
conjunction with HPLC or gel electrophoresis for product analysis, especially if a
homogenous population of oligonucleotides is essential.
BASIC
PROTOCOL 2
DEPROTECTION OF DNA OLIGONUCLEOTIDES
After synthesis is complete, the DNA may be cleaved from the column and protecting
groups removed by treatment with ammonia. Although very extended treatment in base
can harm DNA, hours of ammoniolysis are still preferred to ensure complete deprotection,
since a homogeneous population of “natural” oligonucleotides at slightly lower yield is
better than a mixed population of partially deprotected, “unnatural” molecules.
To cleave the DNA from the support matrix and remove protecting groups completely,
the support-bound product must be treated with concentrated ammonia at 55° to 60°C
overnight (≥12 hr). Even with such extended treatment, deoxyguanosine may not be
completely deprotected (Schulhof et al., 1987). Raising the temperature at which oligonu-
cleotides are deprotected has been reported to speed up the process (≥5 hr at 70°C).
Phosphoramidites with more labile protecting groups such as phenoxyacetyl or dimethyl-
formadine masking adenosine and guanosine have recently become commercially avail-
able (Table A.3C.1). These allow essentially complete deprotection within 30 to 60 min
at 70°C (Reddy et al., 1994). Also, by replacing the traditional benzyl protection of
cytosine with acetyl and using a 1:1 mixture of aqueous ammonium hydroxide and
aqueous methylamine, oligonucleotides synthesized with traditional purine protections
may be completely deprotected in 5 min at 65°C (Reddy et al., 1995). Finally, anhydrous
ammonia gas-phase deprotection of oligonucleotides has recently been described; this
provides a convenient method for parallel deprotection of as many columns will fit in a
reactor. Since no water is present, the fully deprotected oligonucleotides remain adsorbed
to the column matrix, thereby guaranteeing that no cross-contamination will occur. The
oligonucleotides can then be eluted with water and desalted or further purified. Using
PAC-protected monomers, the cleavage and deprotection processes can be completed in
∼30 min (Boal et al., 1996).
Materials
Concentrated (14.8 N) ammonium hydroxide (see recipe)
Triethylamine
3:1 (v/v) concentrated ammonium hydroxide/ethanol
n-Butanol
Screw-cap plastic vial (preferably fitted with rubber O ring)
Heat block or oven, 55° to 60°C
0.2-µm filter
1. In a screw-cap plastic vial, suspend the synthesis support matrix or the already
support-cleaved oligonucleotide in ∼1.0 ml concentrated ammonium hydroxide for
a 1-µmol synthesis.
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Depending on the synthesizer or nucleic acid provider, the oligonucleotide may come
attached to a support matrix or free in an ammonium hydroxide solution. The volume of
ammonium hydroxide in which product is eluted from the synthesizer is variable. The
ammonium hydroxide used should not have been diluted by excessive vapor loss.
2. Place the sample in heat block or oven for ≥12 hr at 55° to 60°C.
Seal vial tightly with Parafilm (if not fitted with a rubber O ring).
3. After cleavage from the support and deprotection are complete, spin the sample
briefly in a tabletop centrifuge to pool the ammonia and support that may have
collected in the cap. Let the vial cool to room temperature before opening it to avoid
sample boil-over.
4. Filter off the support by passing the liquid through an 0.2-µm filter and wash the filter
with 0.3 ml of 3:1 (v/v) ammonium hydroxide/ethanol.
5. Precipitate the oligonucleotide from the resulting supernatant by adding 10 vol
n-butanol and vortexing for 15 sec. Centrifuge 10 min at 16,000 × g, 4°C.
6. Remove and discard the single aqueous n-butanol phase to reveal the white oligonu-
cleotide pellet.
Oligonucleotides 20 residues or shorter with good trityl responses are typically suitable
for use directly in DNA sequencing, PCR amplification, and gel-shift analysis. However, if
more homogenous material is required, methods such as denaturing PAGE and HPLC may
be employed to further purify the full length product.
7. If a yellowish liquid or crusty pellet remains, rather than a white powder, resuspend
the pellet in 0.1 ml distilled water and precipitate again with n-butanol as described
above.
Generally, it is not necessary to add additional salt for precipitation.
Further extraction will aid in removing any residual ammonia or volatile organics. If the
yellow color does not disappear, it will ultimately be removed by almost any of the standard
purification methods.
8. Lyophilize the sample to dryness in a Speedvac evaporator.
This deprotection is primarily intended for oligonucleotides with the trityl group off. When
the trityl group is left on, care must be taken that it is not prematurely hydrolyzed from the
DNA by acid conditions. During lyophilization, a drop of triethylamine must be added
regularly to the sample in order to maintain its basicity (Applied Biosystems, 1988).
Heating of the samples should be avoided.
BASIC
PROTOCOL 3
DEPROTECTION OF RNA OLIGONUCLEOTIDES
Techniques and recommendations for deprotecting RNA are similar to those for DNA.
Ammoniolysis cleaves the RNA from the support and frees the bases of their protecting
groups. Additionally, the 2′ hydroxyl protecting group must be removed to reveal a
functional RNA sequence. Reagents, water, and plasticware to which RNA is exposed
must be sterile. The protocol detailed below is for use with nucleosides bearing the
standard isobutyryl and benzyl protection on the bases and 2′ silyl protection. Protection
options are becoming available that both increase yield and streamline deprotection time
(Table A.3C.1).
Materials
100% ethanol
3:1 (v/v) concentrated (14.8 N) ammonium hydroxide/ethanol
3 M sodium acetate, pH 5.2 (APPENDIX 2A)
Triethylamine trihydrofluoride
Screw-cap plastic vial (preferably fitted with rubber O ring)
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Heat block or oven, 55° to 60°C
0.2-µm filter
Sephadex G-25 column (Amersham Pharmacia Biotech)
1. In a screw-cap plastic vial, suspend the synthesis support matrix or the already
support-cleaved oligonucleotide in ∼1.2 ml of 3:1 (v/v) ammonium hydroxide/etha-
nol for up to a 1-µmol scale.
Depending on the synthesizer or nucleic acid provider, the oligo may come attached to a
support matrix or free in an ammonium hydroxide solution. The volume of ammonium
hydroxide in which product is eluted from the synthesizer is variable. The ammonium
hydroxide used should not have been diluted by excessive vapor loss.
2. Place the sample in a heat block or oven for 12 to 16 hr at 55° to 60°C.
Seal vial tightly with Parafilm (if not fitted with a rubber O ring). If fast-cleaving
phosphoramidites such as PAC-protected purines and acyl-protected cytosine are used, the
deprotection time of the bases can be a little as 10 min in methylamine at 65°C (Wincott
et al., 1995).
3. After cleavage from the support and base deprotection are complete, spin the sample
briefly in a tabletop centrifuge to pool the ammonia and support that may have
collected in the cap. Let the vial cool to room temperature before opening it to avoid
sample boil-over.
4. Filter off the support by passing the liquid through an 0.2-µm filter and wash the filter
with 0.3 ml of 3:1 (v/v) ammonium hydroxide/ethanol.
5. Evaporate the combined solutions to dryness in the Speedvac evaporator without
heating. Resuspend the pellet in 0.2 ml of 100% ethanol and evaporate to dryness
without heating.
6. Treat the dried residue with triethylamine trihydrofluoride (0.3 ml for a 0.2-µmol or
0.5 ml for a 1-µmol synthesis). Allow to rotate in a foil-covered screw-cap vial in the
dark for at least 24 but no more than 48 hr.
Alternative methods exist to remove the 2′ silyl protecting groups either under dilute acidic
conditions (Kawahara et al., 1996) or with anhydrous triethylamine/hydrogen flouride in
N-methylpyrrolidinone (Wincott et al., 1995).
7. To desalt via ethanol precipitation, add an equal volume of water to the triethylamine
trihydrofluoride solution and immediately dilute with 1⁄10 vol of 3.0 M sodium acetate,
pH 5.2. Precipitate by adding 3 vol of 100% ethanol and chilling for ∼20 min at
−80°C. Centrifuge 10 min at 16,000 × g, 4°C.
An alternative method exists for isolation of the RNA by diethyl ether precipitation (Song
and Jones, 1999).
8. Remove and discard the single ethanol layer to reveal the white oligonucleotide pellet.
9. If a yellowish liquid or crusty pellet remains, rather than a white powder, resuspend
the pellet in 0.1 ml distilled water and repeat the sodium acetate/ethanol precipitation
as described in step 7. If desired, desalt the RNA on a desalting matrix such as
Sephadex G-25.
REAGENTS AND SOLUTIONS
Use deionized, distilled water in all recipes and protocol steps. For common stock solutions, see
APPENDIX 2A; for suppliers, see SUPPLIERS APPENDIX.
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Acetonitrile, dry
Since large volumes are used for rinsing lines and dissolving other reagents,
acetonitrile is one of the most costly reagents in nucleic acid synthesis. If the DNA
synthesizer is used infrequently, it may be useful to produce small amounts of dry
acetonitrile immediately prior to synthesis since the acetonitrile will accumulate
water after the bottle has been opened. Moisture greatly diminishes synthetic yield.
In this case acetonitrile can be prepared in any laboratory equipped for routine
distillations. However, the time and effort involved in setting up and maintaining a
still should be balanced against the cost of obtaining dry acetonitrile. The use of
molecular sieving pouches that do not release metal ions is recommend; they are
often available from the synthesizer manufacturer and should keep the acetonitrile
to <20 ppm water. Some commercial suppliers now market bulk solvents specifically
for nucleic acid synthesis (e.g., Baker “low-water” acetonitrile, 0.002% or 20 ppm
water; Burdick and Jackson acetonitrile, 0.001% or 10 ppm water). The cost of these
special dry reagents is about the same as that of HPLC-grade acetonitrile (which
typically contains 0.01% or 100 ppm water), which is the starting material for a
laboratory distillation.
CAUTION: Acetonitrile vapor is poisonous.
Ammonium hydroxide
Purchase concentrated (14.8 N) ammonium hydroxide in 0.5- to 1.0-liter bottles,
and store it at 4°C to reduce the ammonia gas found in the vapor phase above the
liquid.
CAUTION: Concentrated ammonium hydroxide is extremely caustic. Breathing the vapors
is harmful. Always use this compound in the fume hood, as it is possible to be quickly
overcome by ammonia fumes and blinded.
Ammonia is volatile and its concentration will decrease on repeated opening, until it is no
longer completely functional as a deprotecting reagent. When this occurs, obtain a fresh
supply.
Oxidizer
Prepare 0.02 M iodine in 7:2:1 (v/v/v) THF/pyridine/water. Store ≤6 months at room
temperature.
CAUTION: Pyridine is toxic in both liquid and vapor forms.
CAUTION: Iodine is harmful if inhaled. Beware of spills containing both iodine and
ammonia since explosive compounds can be formed.
Most commercial sources of THF contain BHT, a free-radical scavenger that prevents the
buildup of explosive peroxides. This compound has no effect on synthesis chemistry. Any
commercial grade of pyridine is acceptable; use resublimed iodine.
Phosphoramidites
Prepare phosphoramidites in extremely dry, commercially sealed acetonitrile (see
recipe) according to the procedure recommended by the synthesizer manufacturer.
Store ≤6 months at 4°C and discard after 2 weeks.
Some companies recommend dissolving phosphoramidites to give equal molarities of the
four bases, while others recommend a standard weight/volume ratio that will give slightly
different final molar concentrations. The actual phosphoramidite concentration may matter
for some applications—e.g., when making mixed-site oligonucleotides.
COMMENTARY
Critical Parameters
By optimizing the reagents and protocols
used in oligonucleotide synthesis, it is reliably
possible to make products of greater length and
yield, while minimizing the costs associated
with unproductive runs.
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Excluding water from solvents
The most critical factor in any synthesis is
how the reagents are handled to exclude water
from the system. From the moment a bottle is
opened, it is in contact with water in the air, and
all the solvents used are hygroscopic and will
absorb water vapor, which reduces yields. This
problem is so severe that it is advisable to avoid
large-scale, lengthy, or important runs on rainy
or highly humid days.
Special anhydrous reagents can be pur-
chased from most manufacturers of nucleic
acid synthesizers. Additionally, chemical sup-
pliers are now beginning to market solvents
specifically for DNA synthesis. Adding mo-
lecular sieving pouches to the activator and
acetonitrile used before oxidation is extremely
useful in preserving the anhydrous environ-
ment of the phosphoramidite coupling reaction.
Phosphoramidites are the most sensitive to
water contamination because they are easily
hydrolyzed, which renders them unreactive.
Precautions must be taken to avoid exposing
them to even small amounts of water. Very dry
acetonitrile (<0.003% water), kept as a separate
stock and sealed under argon, should be used
to dissolve the phosphoramidites. The acetoni-
trile should be introduced through the septum
on the amidite bottles via a syringe. Glass
syringes can be dried in a 300°C drying oven, then
cooled in a desiccator prior to use. Plastic syr-
inges can be dried in a 45°C vacuum oven.
Disposable plastic syringes from air-tight ster-
ile casings are dry enough to use with acetonitrile
to be dispensed into phosphoramidites with no
additional precautions. The syringe should be
filled with argon or helium prior to drawing up
the acetonitrile, so that wet air is not introduced
into the system. On some synthesizers, this can
be done directly via the phosphoramidite ports.
Otherwise, an argon line should be used.
An argon line is generally a helpful tool for
DNA synthesis chemistry. It consists of an
argon tank with a regulator connected to a piece
of plastic (Tygon) tubing. The tubing is then
fitted with either a Pasteur pipet or a syringe
and needle. Gas flow can be roughly deter-
mined via an in-line “bubbler” (e.g., Aldrich).
Argon from a tank is dry enough so that an
in-line desiccator is unnecessary. It is necessary
to flush the line for several seconds prior to use.
Empty bottles can be dried under an argon
stream, which will help to exclude condensa-
tion from the air. Partially used reagents should
be sealed under an argon layer to prevent equili-
bration with water vapor in the air (the heavier
argon will exclude air from the containers).
Choosing synthesis columns
Automated DNA synthesis generally takes
place on a solid support made of controlled-
pore glass (CPG; see UNITS 3.1 & 3.2). This is a
porous, nonswelling particle, 125 to 177 µm in
diameter, that is derivatized with a terminal
nucleotide attached to a long spacer arm. The
accessibility of the growing end of the oligonu-
cleotide chain is influenced by the pore size of
the particle. It has been recommended that
oligonucleotides up to 50 bases in length should
be synthesized on CPG with ∼500-Å pores,
while longer oligonucleotides should be syn-
thesized on CPG with ∼1000-Å or larger pores.
Be sure that the column geometry is compatible
with the trityl monitor. Also, when packing
columns be sure to purge the column first with
dry acetonitrile and then with dry argon to
ensure that all CPG particles are caught be-
tween the filters, since loose particles can dam-
age the synthesizer.
CPG columns are available that contain ∼0.2
to 10.0 µmol of linked nucleotides. In general
larger loadings are used for larger oligonu-
cleotides since as the size of the oligonucleotide
increases, the overall yield decreases. Also,
subsequent purification steps invariably in-
volve losses, and the amount of product of
correct length must be kept high to ensure that
there is enough material. Oligonucleotides >35
bases should be synthesized on 1.0-µmol CPG
columns. See Synthesizing Long Oligonu-
cleotides for discussion of choosing a column
when synthesizing ≥100-base oligonucle-
otides.
Alternatively, columns that are more heavily
derivatized with the 3′ terminal nucleotide are
available as solid supports (e.g., Fractosil, from
Merck), and a higher yield of product per col-
umn (and per amount of reagent delivered) can
be obtained using these columns. However,
Fractosil is not recommended for synthesizing
oligonucleotides >20 bases long.
Synthesis chemistry
Regardless of reagent and final product pu-
rity, there are inherent limitations in the chem-
istry used for the synthesis of oligonucleotides.
Therefore, it is necessary to understand the
differences between chemically synthesized
and biologically derived DNA.
Failure to produce “natural” DNA can be
due to the synthesis chemistry used. Methyla-
tion of some bases can occur during deprotec-
tion with thiophenol in methyl phosphor-
amidite–based syntheses. Under standard syn-
thesis conditions, these methylated bases can
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account for up to 7% of the nucleotides present,
with N-3-methyl-dT being the primary modi-
fied base (Farrance et al., 1989). However, this
problem does not always occur—some such
syntheses have been reported to contain 99.9%
dA, dG, dT, and dC. In general, this problem can
be avoided by increasing the time of the thiophe-
nol deprotection step to between 60 and 90 min.
With both methyl and β-cyanoethyl chem-
istries, the glycosidic bond of N-protected
purine phosphoramidites is subject to hydroly-
sis during DMT removal with acid. Such depu-
rination eventually leads to strand cleavage
during the ammonia deprotection step. N-pro-
tected adenosine is more sensitive to depurina-
tion than guanosine, and it is most sensitive
when located at the 5′ end of an oligonucleotide
chain (Tanaka and Letsinger, 1982).
In order to maintain low levels of depurina-
tion, the deblocking step should not be longer
than ∼1 min. Additionally, the mildest effective
acid (DCA rather than TCA) should be used.
Occasionally, however, protected nucleotides
are supplied as monomethoxytrityl (MMT) es-
ters, which are 10-fold more resistant to acidic
detritylation. Oligonucleotides synthesized
with MMT as a protecting group are more
susceptible to depurination, since the deblock-
ing step must be correspondingly lengthened to
achieve complete detritylation and high yields.
In cases where only one base is being added as
the MMT compound, it is recommended that
this step be performed manually, so that the
nucleotides are subjected to only one lengthy
acid treatment.
Advances in oligonucleotide synthesis
chemistry may mitigate the problems associ-
ated with depurination. Recently, nucleotides
derivatized with protecting groups that render
synthesized material less sensitive to depurina-
tion have become commercially available
(Schulhof et al., 1987; Pharmacia, 1989).
Reagents
Most reagents may be purchased from the
synthesizer manufacturer or from companies
that specialize in reagents for nucleic acid syn-
thesis; however, some labs choose to make their
own reagents to reduce costs. Notes on the
preparation and storage of certain reagents are
provided above. Other reagents should prob-
ably be purchased from commercial sources, as
the preparation of anhydrous materials is more
difficult and expensive than most molecular
biology labs can support. An appropriate text
should be consulted on the medical dangers of
all solutions and reagents used in DNA synthe-
sis (see Key References). Most suppliers of
materials have a fairly extensive list of products
available on-line.
Troubleshooting
Rescue after reagent depletion
Most synthesizer problems require a visit
from the service engineer. However, syntheses
during which reagent or solvent bottles run
empty can sometimes be rescued. Certain in-
struments respond to depleted reagents during
a synthesis by continuing the synthesis or stop-
ping. For instruments that stop, it may be pos-
sible to recover oligonucleotides, depending on
which reservoir was depleted. It is important
that the lines be rinsed after an empty reservoir
has been detected (some machines perform this
step automatically). Otherwise, the oligonu-
cleotide should be resynthesized. Many ma-
chines have the capacity to restart in the
middle of a cycle, and if not, the cycle can be
finished manually. The exact procedure will
vary depending on which reagent has been
exhausted.
Acetonitrile. This is quite serious. The lines
cannot be rinsed of whatever reagent they last
contained; thus, determine whether to continue
with the synthesis based on the reactivity of the
last reagent in the lines.
Deblocking reagent. Refill the reservoir. The
machine can continue at the beginning of the
cycle that was interrupted, but full-length yield
will greatly suffer.
Phosphoramidites. Refill the reservoir and
perform manual coupling. In this way, the
chains that did elongate will not form n + 1
products, and those that did not will have a
chance to elongate. Programmed synthesis can
be resumed with the next cycle.
Capping reagent. Perform a manual capping
and complete the cycle manually, at which
point programmed synthesis can resume. This
ensures that capping is efficient for this cycle
and avoids accumulation of n − 1 sequences.
Oxidizer. Running out of oxidizer is particu-
larly dangerous, because the unstable phosphite
linkages remain on the column for long periods.
It is best to discard the material; otherwise,
perform a manual oxidation and continue with
the synthesis.
Ammonium hydroxide. Some material may
be left on the column if ammonium hydroxide
runs out during the course of synthesis. Refill
the bottle and pump more ammonium hydrox-
ide through the column, or remove the column
and treat with ammonium hydroxide.
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Thiophenol. Refill the thiophenol reservoir.
Restart from the deprotection step. At worst, a
small amount of product may have cleaved
because of inefficient methyl deprotection.
Routine maintenance
To avoid other purely mechanical problems
with a DNA synthesizer, create a regular main-
tenance schedule to perform a few minor main-
tenance tasks. Change the various frits and
filters that remove debris before they enter the
system; furthermore, remove the deposits of
salt and debris as these may affect flow rates
and decrease volumes delivered. Change the
filters on the acetonitrile bottle more often,
because the flow of this reagent is much greater
than any other. Also, change any rubber O rings
every few months. Rinse all the instrument’s
lines with base and organic solvents thoroughly
every 500 hr of machine use or approximately
every 3 months. Finally, rinse the lines exten-
sively with dry acetonitrile. Finish the general
maintenance by checking the flow rates of the
instrument after cleaning and then synthesize a
small oligonucleotide. Monitor the trityls care-
fully in order to confirm that the cleaning did not
affect any aspect of the synthesis cycle. If this
regimen is followed, many minor delays encoun-
tered in the synthesis schedule can be avoided.
Anticipated Results
When the synthesizer is working properly
(>98% coupling efficiency), typical yields of
deoxyoligonucleotides 20 bases in length at the
1-µmol scale, as measured from the trityl re-
sponse, are nearly 60%. Also, these shorter
deoxyoligonucelotides are typically suitable
for DNA sequencing, PCR amplification, and
gel-shift analysis without extensive purifica-
tion. However, if very homogenous material is
required, further purification must be done,
because many sequences will be truncated.
Longer DNA sequences are generally obtained
in lesser yield and quality and should be puri-
fied. Sequences of >120 bases are generally
obtained in ≤10% yield as measured by the
trityl response. Yields for RNA sequences are
typically much lower than for their DNA coun-
terparts of a given length, and the products must
be extensively purified.
Time Considerations
On a typical day when most of the bottles
on the synthesizer need refilling, it may take 30
to 60 min to fill the bottles, empty waste, install
columns, and rinse and prime the lines prior to
starting a synthesis. The most time-consuming
syntheses are those involving doped oligonu-
cleotides, which require a high level of preci-
sion in distributing the various phosphor-
amidites to the appropriate bottles. A computer
interfaced with the instrument can increase syn-
thesis accuracy and throughput. Instruments
take varying amounts of time to synthesize
oligonucleotides depending on the number of
columns in use, the length of the oligonu-
cleotide, and the synthesis program. Deprotec-
tion and isolation of a standard DNA oligonu-
cleotide will probably take one working day,
while RNA oligonucleotides take longer because
of the extra deprotection and desalting steps.
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